Evid Invest
Who owns IONSWhat IONS owns — n/a

Who owns IONIS PHARMACEUTICALS INC?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of IONS from SEC Form 13F filings across 464 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 464 institutions disclosed 176.3M shares of IONIS PHARMACEUTICALS INC worth $7.87B — about 106.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

464

13F holders

$7.87B

value, 2026 filers

106.1%

of shares outstanding (176.3M sh)

70

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IONS's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC24.7M$1.10B0.0%14.9%+0.4%
2Capital World Investors21.8M$972.8M0.1%13.1%+0.5%
3BlackRock, Inc.13.2M$589.1M0.0%7.9%+23.2%
4VANGUARD PORTFOLIO MANAGEMENT LLC7.7M$344.7M0.0%4.6%-1.8%
5VANGUARD CAPITAL MANAGEMENT LLC7.2M$322.3M0.0%4.3%+0.1%
6TWO SIGMA INVESTMENTS, LP6.7M$300.4M0.2%4%+7.6%
7STATE STREET CORP5.7M$255.0M0.0%3.4%+31.7%
8ROYAL BANK OF CANADA4.8M$214.8M0.0%2.9%-22.2%
9CITADEL ADVISORS LLC4.0M$179.8M0.0%2.4%+1604.0%
10WELLINGTON MANAGEMENT GROUP LLP3.4M$153.2M0.0%2.1%-55.2%
11GEODE CAPITAL MANAGEMENT, LLC3.3M$146.4M0.0%2%-8.6%
12MORGAN STANLEY3.1M$140.4M0.0%1.9%+145.3%
13T. Rowe Price Investment Management, Inc.3.0M$135.9M0.1%1.8%-23.1%
14DEERFIELD MANAGEMENT COMPANY, L.P.2.7M$118.8M1.8%1.6%+34.4%
15WESTFIELD CAPITAL MANAGEMENT CO LP2.4M$107.2M0.4%1.4%+56594.2%
16Qube Research & Technologies Ltd2.0M$89.1M0.1%1.2%+497.6%
17Pictet Asset Management Holding SA1.9M$87.2M0.1%1.2%+21.7%
18Tweedy, Browne Co LLC1.8M$80.1M6.5%1.1%-21.4%
19CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.8M$78.2M0.0%1.1%+9.1%
20UBS Group AG1.5M$67.3M0.0%0.9%+141.4%
21Polar Capital Holdings Plc1.4M$64.2M0.2%0.9%-1.2%
22UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1.4M$62.8M0.0%0.8%-3.3%
23Alyeska Investment Group, L.P.1.3M$60.2M0.2%0.8%-5.0%
24GW&K Investment Management, LLC1.3M$59.9M0.5%0.8%+79.6%
25PRICE T ROWE ASSOCIATES INC /MD/1.3M$58.1M0.0%0.8%-59.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.